| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/19/2005 | EP1497672A2 Ultrasonic doppler effect speed measurement |
| 01/19/2005 | EP1497278A1 Heterocyclic amide derivatives as cytokine inhibitors |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1497245A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
| 01/19/2005 | EP1496896A1 Inhibitors of akt activity |
| 01/19/2005 | EP1334095B1 Process for the preparation of pgd2 antagonist |
| 01/19/2005 | CN1568326A Method for producing, via organometallic compounds, organic intermediate products |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568303A Oligofluorenylene compounds |
| 01/19/2005 | CN1568298A Luminous compounds and labeling reagents using the same |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1185226C Intermediate for preparing benzothiophene amide derivate |
| 01/19/2005 | CN1185225C Improved process for preparing nitrogen-substituted aminotetralins |
| 01/18/2005 | US6844367 Benzamides and related inhibitors of factor Xa |
| 01/18/2005 | US6844358 Protein tyrosine phosphatase inhibitors; benzofuran-3-yl- or benzothiophen-3-yl derivatives; containing pyridinyl, imid-azoyl, oxazoyl or thiazoyl functionality |
| 01/13/2005 | WO2005003116A1 Process for preparing raloxifene hydrochloride |
| 01/13/2005 | WO2005003115A1 Thiophene amino acid derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/13/2005 | WO2005003114A1 5-fluoro-thiopen-compounds,the process for their preparation,the pharmaceutical compositions containing them and their use as metallopotenases inhibitors |
| 01/13/2005 | US20050010058 Metallocene compounds and process for the preparation of propylene polymers |
| 01/13/2005 | US20050009920 Taxol enhancer compounds |
| 01/13/2005 | US20050009912 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; treatment of neurological or psychiatric disorders, such as anxiety disorder; greatly enhanced oral exposure |
| 01/13/2005 | US20050009907 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | US20050009804 N-heterocyclyl- or cycloalkyl-N-(2-carboxy-5-aryl-3-thiophenyl)cycloalkanecarboxamides, e.g., 5-(3-fluorophenyl)-3-[isopropyl-(4-methylcyclohexanecarbonyl)amino]-thiophene-2-carboxylic acid; especially for prevention and treatment of HVC |
| 01/13/2005 | DE10328400A1 One-pot synthesis of carbocyclic or heterocyclic compounds, especially pyrimidine useful as components of natural products or drugs, from acid halide, alkyne and active hydrogen compound |
| 01/13/2005 | CA2549354A1 Process for preparing raloxifene hydrochloride |
| 01/12/2005 | EP1495015A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/12/2005 | EP1030851B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841669 Functionalized thiophene oligomers and their use as fluorescent markers |
| 01/11/2005 | US6841569 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants |
| 01/11/2005 | US6841553 Contorlling fertility |
| 01/11/2005 | US6841499 Homogeneous rhodium complexes bearing phosphines |
| 01/11/2005 | US6840965 P-aminophenols and colorants containing said compounds |
| 01/06/2005 | WO2005002288A1 Conjugate molecule, electroluminescent element using the same and electronic apparatus using the electroluminescent element |
| 01/06/2005 | WO2005000839A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | WO2005000834A1 Pentafluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators |
| 01/06/2005 | WO2005000833A1 Immunosuppressant compounds and compositions |
| 01/06/2005 | WO2005000829A1 Cannabinoid receptor modulator |
| 01/06/2005 | WO2005000790A1 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| 01/06/2005 | WO2005000781A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | US20050004252 Light emitting polymer |
| 01/06/2005 | US20050004251 Light emitting polymer |
| 01/06/2005 | US20050004212 Antitumor/cancer activity; topoisomerase I inhibitors |
| 01/06/2005 | US20050004211 Inhibiting topoisomerase I; blocking S or G2/M phase of tumor and/or cancer cells |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/06/2005 | CA2672071A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2556706A1 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | CA2531020A1 Cannabinoid receptor modulator |
| 01/06/2005 | CA2530377A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2530309A1 Process for the preparation of insulin sensitizer and intermediate compound thereof |
| 01/06/2005 | CA2529875A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | CA2524048A1 Immunosuppressant compounds and compositions |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 01/05/2005 | EP1493741A2 Benzo[b]thiophene compounds, intermediates, processes, compositions and methods |
| 01/05/2005 | EP1493740A1 5-fluoro-thiophene compounds, the process for their prepartion, the pharmaceutical compositions containing them and their use as metalloproteinases inhibitors |
| 01/05/2005 | EP1493739A1 Thiophene derivatives of aminoacids, process for the preparation thereof and compositions containing them |
| 01/05/2005 | EP1492795A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/05/2005 | EP1492794A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 01/05/2005 | EP1492783A1 4,5,6,7-tretrahydrobenzo(b) thiophene derivatives and methods for medical intervention against mycrobacterial infections |
| 01/05/2005 | EP1492781A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 01/05/2005 | EP1492534A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 01/05/2005 | EP1027051B1 Antithrombotic agents |
| 01/05/2005 | CN1183126C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 01/04/2005 | US6838584 Estrogen receptor modulators |
| 01/04/2005 | US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 01/04/2005 | US6838472 Substituted urea retinoid agonists |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/30/2004 | US20040266857 11,12-dehydro-naphtho[1,2-b]thioxane-9,10-dione derivatives; antiproliferative agents; psoriasis, cancer |
| 12/30/2004 | US20040266856 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 12/30/2004 | US20040266827 Convergent asymmetric route to produce a key intermediate towards the synthesis of a garft inhibitor |
| 12/30/2004 | US20040266789 Substituted amino carboxylic acids |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/29/2004 | WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | WO2004113328A1 Convergent asymmetric synthesis route to produce a key intermediate towards the synthesis of a garft inhibitor |
| 12/29/2004 | WO2004113289A2 Glycosidase inhibitors and methods of synthesizing same |
| 12/29/2004 | WO2004113282A1 Therapeutic agents |
| 12/29/2004 | WO2004113281A1 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 12/29/2004 | WO2004113273A1 Pesticidally active ketone and oxime derivatives |
| 12/29/2004 | WO2004113258A1 Carbon-carbon bond forming reaction |
| 12/29/2004 | WO2004099175A3 Blockers of the quorum sensing system of gram-negative bacteria |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | EP1491538A1 Anti-mitotic agents which inhibit tubulin polymerization |
| 12/29/2004 | EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |